US awaits FDA appointment

被引：0

作者：

Ault, A

机构：

来源：

关键词：

D O I：

10.1038/85374

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：264 / 264

页数：1

共 50 条

[31] What awaits us? And what do we want?
不详
REVISTA ROL DE ENFERMERIA, 2008, 31 (05): : 328 - 328
[32] FDA appointment is stalled as revelations emerge over Plan B
Tanne, Janice Hopkins
BRITISH MEDICAL JOURNAL, 2006, 333 (7563): : 317 - 317
[33] What Awaits Us after the Non-Human Turn?
Timofeeva, Oxana
NOVOE LITERATURNOE OBOZRENIE, 2019, (158): : 26 - 34
[34] US building materials industry awaits positive market mood
Wiener, Martin
ZKG INTERNATIONAL, 2017, 70 (05): : 59 - 59
[35] A new frontier awaits for US particle-physics lab
Banks, Michael
PHYSICS WORLD, 2009, 22 (03) : 12 - 13
[36] What awaits? What awaits?
Ladanyi, Istvan
KNJIZEVNA SMOTRA, 2009, 41 (02): : 161 - 163
[37] US appointment - Zerhouni confirmed as NIH director
Kaiser, J
SCIENCE, 2002, 296 (5570) : 997 - +
[38] US-FDA Filing
Geetha, L.
Swarnakumari, P.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 71 (02) : 191 - 191
[39] Aubagio approved by US FDA
O'Hare, Alice
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2012, 8 (08) : 703 - 703
[40] US FDA GuidanceApropos of PROs
Paul Kind
PharmacoEconomics, 2006, 24 : 833 - 836